Novartis reportedly decides to pass on Cytokinetics

Off Biotech, biotechnology, Business, drug development, drug prices, drug pricing, FDA, finance, government agencies, Health, Human Health, legal, Life Sciences, Medicine, mental health, Pharma, Pharmaceuticals, Politics, Science and Research, The Readout

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Hiya! Did you catch every last important bit of news that emerged from this year’s JPM conference? Join STAT’s Tara Bannow, Damian Garde, Matthew Herper, and Allison DeAngelis today for a virtual debrief on how the week went.

Read the rest…

Read Original Article: Novartis reportedly decides to pass on Cytokinetics »

About The Author